Disclosure Of Entity's Operating Segments [Text Block]

Transgene - Filing #6250839

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Note 21
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
- EUR
- EUR
Profit (loss) before tax
33 971 EUR
22 328 EUR
Profit (loss)
33 971 EUR
- EUR
- EUR
33 971 EUR
- EUR
- EUR
- EUR
- EUR
22 328 EUR
- EUR
22 328 EUR
- EUR
- EUR
- EUR
Assets
42 174 EUR
45 217 EUR
Liabilities
26 970 EUR
29 605 EUR
Cash flows from (used in) operating activities
23 548 EUR
34 671 EUR
Cash flows from (used in) investing activities
3 206 EUR
34 572 EUR
Cash flows from (used in) financing activities
26 959 EUR
11 369 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.